YP

Yegireddi Prasanna

Active Director Director DIN 10649091
DIN 10649091 First appointment Jun 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Yegireddi Prasanna

Data last updated:

Yegireddi Prasanna is a Director at Cric Pharma Private Limited (since 2024). The company operates in Chemicals. Cric Pharma Private Limited reported revenue of ₹2.9 Lakh (FY 2024).

DIN 10649091
Primary Designation Director
Industry Chemicals
First Appointment 06 Jun 2024
Oldest Company Age 5 yrs
Largest company Cric Pharma Private Limited · ₹2.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cric Pharma Private Limited U24230TG2021PTC154049
Director06 Jun 20242021₹2.9 Lakh (FY 2024)Active

Board colleagues of Yegireddi Prasanna

NameDINCompanyDesignation
Srinivasa Rao10649219Cric Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cric Pharma Private Limited
Premium access

Shareholding and investment profile for Yegireddi Prasanna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yegireddi Prasanna

Yegireddi Prasanna currently holds 1 directorship: Cric Pharma Private Limited (Director, since 06 Jun 2024, revenue ₹2.9 Lakh (FY 2024)).

Yegireddi Prasanna was first appointed on 06 Jun 2024 as Director at Cric Pharma Private Limited.

The current boards of Yegireddi Prasanna's companies include Srinivasa Rao (Cric Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available